CARDIFF, Calif. (AP) — CARDIFF, Calif. (AP) — Viracta Therapeutics, Inc. (VIRX) on Thursday reported a loss of $9.1 million in its first quarter.
The Cardiff, California-based company said it had a loss of 23 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 35 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VIRX at https://www.zacks.com/ap/VIRX
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
